ChromaGenix
PrivateLast Round
Corporate Funding
Apr 22, 2025
Company Overview
ChromaGenix is a biotechnology company that develops and manufactures synthetic affinity ligands and chromatography resins to improve the purification of complex biologics such as gene therapies, vaccines, and antibodies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ChromaGenix Comparables
Compare ChromaGenix with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Repligen Corporation | 79% | |
| Danaher | 77% | |
| Merck | 77% | |
ChromaGenix Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Corporate Funding | Apr 22, 2025 |
ChromaGenix Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| BioProcess 360 Partners | Corporate Funding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 22, 2025
$35M round led by BioProcess 360 Partners.
ChromaGenix Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about ChromaGenix's valuation, stock price, and market status.